Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: Eric Urquhart/Shutterstock.com There’s loads of movement from penny stocks t...
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today provided a business update, including preliminary unaudited full-year 2021 revenue results. Amarin plans to discuss these results and expectations with investors in connection...
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that Karim Mikhail, president and chief executive officer of Amarin, is scheduled to present virtually at the 40 th Annual J.P. Morgan Healthcare Conference on ...
Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market Intelligence . The silver lining is that the biotech's shares didn't crater in response to...
3 Penny Stocks That Could Be Worth Watching in December With December moving as fast as it came, there are plenty of penny stocks that could be worth watching. As we’ve stated numerous times in the past week or so, the main contributing factor to stock market volatility right now...
Amarin is a pharmaceutical company offering products to improve cardiovascular health. The company’s clinical results are quite successful. We are talking about 20% reduction in cardiovascular deaths. The company expects to launch products in approximately 20 additional mar...
3 Penny Stocks For Your Watchlist Right Now With another day of trading penny stocks here, which small caps are the best for investors to watch right now? Well, to understand that, we have to take a look at the most current penny stocks trends and how they may affect your portfolio ...
Shares of biotech Amarin (NASDAQ: AMRN) shot more than 3% higher on Tuesday. That was on the reveal that an activist investor has taken an equity stake in the business. In a regulatory filing submitted after market hours on Monday, hedge fund Sarissa Capital Management revealed ...
Gainers: Kezar Life Sciences KZR +36%, Progenity (NASDAQ:PROG) +28%, GeoVax Labs GOVX +15%, Medicenna Therapeutics (NASDAQ:MDNA) +15%, Amarin AMRN +10%. Losers: Talkspace TALK -37%, OptiNose OPTN -34%, Molecular Partners MOLN...
Amarin (NASDAQ:AMRN) rose 11% after activist investor Sarissa Capital disclosed a new stake in the company. Sarissa unveiled owning 8.5M shares, or a 2.15%, stake in Amarin, according to a 13-F filing. Recall in June the Supreme Court rejected the Amarin's (AMRN) bid to revive Vasce...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...